NRC Health
NRC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000070487
No open-market purchases or sales by NRC Health insiders were filed in the last 90 days; 123 institutions reported holding it in 13F filings for Q2 2026, worth $231.9M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in NRC Health as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 111
- +1 vs. Q2 2022
- Shares held
- 11.7M
- +154.9K (+1.3%) vs. Q2 2022
- Total value
- $464.7M
- +$23.7M (+5.4%) vs. Q2 2022
- New holders
- 5
- 42 more added
- Sold out
- 4
- 45 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 123 | $231.9M |
| Q1 2026 | 121 | $184.2M |
| Q4 2025 | 117 | $201.6M |
| Q3 2025 | 119 | $142.0M |
| Q2 2025 | 126 | $196.1M |
| Q1 2025 | 123 | $147.3M |
| Q4 2024 | 133 | $209.6M |
| Q3 2024 | 138 | $273.5M |
| Q2 2024 | 136 | $280.3M |
| Q1 2024 | 142 | $505.2M |
| Q4 2023 | 132 | $476.7M |
| Q3 2023 | 121 | $538.4M |
| Q2 2023 | 116 | $507.8M |
| Q1 2023 | 125 | $498.7M |
| Q4 2022 | 116 | $437.3M |
| Q3 2022 | 111 | $464.7M |
| Q2 2022 | 110 | $441.0M |
| Q1 2022 | 116 | $456.3M |
| Q4 2021 | 113 | $473.7M |
| Q3 2021 | 109 | $473.7M |
| Q2 2021 | 101 | $514.2M |
| Q1 2021 | 99 | $511.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding NRC Health; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Touchstone Capital, Inc. | 285,505 | $11.4M | 13.26% | +1,541+0.5% | Added |
| Geode Capital Management, LLC | 297,200 | $11.8M | 0.00% | +5,969+2.0% | Added |
| State Street Corp | 303,783 | $12.2M | 0.00% | +7,110+2.4% | Added |
| Renaissance Technologies LLC | 393,084 | $15.6M | 0.02% | −34,700−8.1% | Reduced |
| QV Investors Inc. | 464,320 | $18.5M | 1.78% | +1,040+0.2% | Added |
| Dimensional Fund Advisors LP | 628,330 | $25.0M | 0.01% | +343+0.1% | Added |
| Conestoga Capital Advisors, LLC | 731,621 | $29.1M | 0.57% | +486+0.1% | Added |
| Vanguard Group Inc | 851,253 | $33.9M | 0.00% | +6,494+0.8% | Added |
| BlackRock Inc. | 932,926 | $37.1M | 0.00% | −26,604−2.8% | Reduced |
| Atlanta Capital Management Co L L C | 959,130 | $38.2M | 0.17% | +172,163+21.9% | Added |
| Kayne Anderson Rudnick Investment Management LLC | 3,232,995 | $128.7M | 0.43% | −13,649−0.4% | Reduced |
| Trexquant Investment LP | 0 | $0 | 0.00% | −5,918−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −168−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −46−100.0% | Sold out |